| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 208.32▲ | 207.83▲ | 207.72▲ | 199.96▲ | 194.34▲ |
| MA10 | 208.16▲ | 206.95▲ | 206.27▲ | 194.28▲ | 183.24▲ |
| MA20 | 207.65▲ | 205.99▲ | 205.83▲ | 189.53▲ | 163.25▲ |
| MA50 | 206.47▲ | 202.12▲ | 196.73▲ | 178.93▲ | 131.83▲ |
| MA100 | 205.54▲ | 195.86▲ | 192.06▲ | 157.42▲ | 110.59▲ |
| MA200 | 203.51▲ | 191.54▲ | 187.09▲ | 133.41▲ | 95.21▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.061▲ | 0.075▲ | -0.093▼ | 1.557▲ | 3.551▲ |
| RSI | 70.344▲ | 61.855▲ | 65.157▲ | 73.111▲ | 87.479▲ |
| STOCH | 74.210 | 90.284▲ | 82.656▲ | 74.072 | 87.965▲ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -8.380▲ | -3.511▲ |
| CCI | 165.549▲ | 137.549▲ | 157.909▲ | 184.806▲ | 156.665▲ |
| ▲ RSI | $LGND RSI(14) Crossed Above 70 | Set Alert |
|
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Monday, November 10, 2025 01:54 PM
Research and development expenses for the third quarter of 2025 were $14.0 million, compared with $11.6 million for the third quarter in 2024. The increase was primarily due to additional costs ...
|
|
Monday, November 10, 2025 01:00 PM
Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMI™Xepi is a novel FDA-approved topical treatment for impetigo that addresses a critical unmet need in ...
|
|
Monday, November 10, 2025 12:34 PM
LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported outstanding results for its third quarter, with revenues almost double our estimates and adjusted core ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 204.44 | 209.30 | 201.50 | 209.29 | 245,659 |
| 07/11/25 | 205.45 | 207.25 | 201.87 | 202.48 | 209,200 |
| 06/11/25 | 196.00 | 211.915 | 186.96 | 208.22 | 468,148 |
| 05/11/25 | 189.00 | 193.07 | 187.91 | 190.38 | 185,714 |
| 04/11/25 | 188.20 | 191.46 | 186.28 | 189.45 | 249,400 |
| 03/11/25 | 192.97 | 193.02 | 183.91 | 191.24 | 269,500 |
| 31/10/25 | 187.78 | 192.76 | 187.43 | 191.31 | 377,475 |
| 30/10/25 | 184.44 | 188.77 | 184.44 | 187.06 | 99,957 |
| 29/10/25 | 187.80 | 191.88 | 182.87 | 184.52 | 169,162 |
| 28/10/25 | 189.51 | 194.44 | 187.965 | 188.87 | 256,969 |
|
|
||||
|
|
||||
|
|